Evaluation of Computer Generated After Visit Summaries

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Valory Pavlik, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT01685541
First received: September 12, 2012
Last updated: September 13, 2012
Last verified: September 2012
  Purpose

The electronic medical record (EMR) offers a new method to provide patients with information about their visits with a clinician. The EMR can generate personalized and patient specific handouts at the end of the visit that can recap the topics covered during that visit. These After Visit Summaries (AVS) can be automatically generated with information contained in the patient's chart. The AVS has the potential to improve patient retention of information needed for adherence to treatment plans, and follow-up instructions, and to facilitate information transfer between healthcare settings. However, the content and formatting of the AVS to optimize patients' information retention and satisfaction with the visit is not known. In this study, we will develop and test in a randomized trial three different versions of an AVS to determine the AVS content that maximizes patient satisfaction and retention of information on the AVS,and adherence to physician instructions. The three versions of the AVS developed from patient and physician input will be compared to a control condition which consists of current practice in each setting.


Condition Intervention Phase
Primary Care Patients With Chronic Conditions
Other: Maximum After Visit Summary Content
Other: Intermediate After Visit Summary Content
Other: Minimum After Visit Summary Content
Other: Usual AVS
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Evaluation of Computer Generated After Visit Summaries to Support Patient-Centered Care

Further study details as provided by Baylor College of Medicine:

Primary Outcome Measures:
  • Recall of After Visit Summary Content [ Time Frame: 2 days post visit ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Satisfaction with the After Visit Summary [ Time Frame: 2 days post visit ] [ Designated as safety issue: No ]

Other Outcome Measures:
  • Adherence to physician treatment recommendations [ Time Frame: 2 days post visit and 2 weeks post visit ] [ Designated as safety issue: No ]

Enrollment: 272
Study Start Date: December 2010
Study Completion Date: June 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Maximum AVS Content
AVS includes patient name, visit date, chief complaining, allergies, immunizations, vital signs, medications, problem list, lab order, physician contact information, referrals, instructions
Other: Maximum After Visit Summary Content
Experimental: Intermediate AVS content
AVS includes patient name, visit date, vital signs, medications, diagnosis, problem list, physician contact information, referrals, instructions
Other: Intermediate After Visit Summary Content
Experimental: Minimum AVS content
AVS contains patient name, visit date, medications, diagnosis, physician contact information, referrals, instructions
Other: Minimum After Visit Summary Content
Active Comparator: Control Group (Usual AVS)
Content differed by clinic site
Other: Usual AVS

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria

  • Adult 21 or over
  • At least one previous visit to the clinic
  • Has one chronic condition require medications
  • Willing to participate and answer questionnaires by phone

Exclusion Criteria:

  • No previous visits to the clinic
  • Unwilling to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Valory Pavlik, Associate Professor, Baylor College of Medicine
ClinicalTrials.gov Identifier: NCT01685541     History of Changes
Other Study ID Numbers: HHSA29010007
Study First Received: September 12, 2012
Last Updated: September 13, 2012
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on July 26, 2014